Bile acids repress hypoxia-inducible factor 1 signaling and modulate the airway immune response

Infection and Immunity

Volumn 82, Issue 9, 2014, Pages 3531-3541

  Legendre, Claire ^a   Jerry Reen, F ^a   Woods, David F ^a   Mooij, Marlies J ^a,c   Adams, Claire ^a   O'Gara, Fergal ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b CURTIN UNIVERSITY   (Australia)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; HYPOXIA INDUCIBLE FACTOR 1; INTERLEUKIN 6; INTERLEUKIN 8; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; REPRESSOR PROTEIN;

ARTICLE; BACTERIAL INFECTION; CASE REPORT; CELL STRUCTURE; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; CYTOTOXICITY; CYTOTOXICITY ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTROESOPHAGEAL REFLUX; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; LUNG ALVEOLUS EPITHELIUM; LUNG INFECTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

BILE ACIDS AND SALTS; CELL LINE; CELL LINE, TUMOR; EPITHELIAL CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFLAMMATION; INTERLEUKIN-6; INTERLEUKIN-8; PROLYL HYDROXYLASES; PROTEASOME ENDOPEPTIDASE COMPLEX; RESPIRATORY SYSTEM; SIGNAL TRANSDUCTION;

EID: 84906070281     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00674-13     Document Type: Article

References (56)

1. Sweet MP, Patti MG, Hoopes C, Hays SR, Golden JA. 2009. Gastrooesophageal reflux and aspiration in patients with advanced lung disease. Thorax 64:167-173. http://dx.doi.org/10.1136/thx.2007.082719.
2. Blondeau K, Dupont LJ, Mertens V, Verleden G, Malfroot A, Vandenplas Y, Hauser B, Sifrim D. 2008. Gastro-oesophageal reflux and aspiration of gastric contents in adult patients with cystic fibrosis. Gut 57:1049-1055. http://dx.doi.org/10.1136/gut.2007.146134.
3. Blondeau K, Pauwels A, Dupont L, Mertens V, Proesmans M, Orel R, Brecelj J, Lopez-Alonso M, Moya M, Malfroot A, De Wachter E, Vandenplas Y, Hauser B, Sifrim D. 2010. Characteristics of gastroesophageal reflux and potential risk of gastric content aspiration in children with cystic fibrosis. J. Pediatr. Gastroenterol. Nutr. 50:161-166. http://dx.doi.org/10.1097/MPG.0b013e3181acae98.
4. Hallberg K, Fandriks L, Strandvik B. 2004. Duodenogastric bile reflux is common in cystic fibrosis. J. Pediatr. Gastroenterol. Nutr. 38:312-316. http://dx.doi.org/10.1097/00005176-200403000-00016.
5. Ledson MJ, Tran J, Walshaw MJ. 1998. Prevalence and mechanisms of gastro-oesophageal reflux in adult cystic fibrosis patients. J. R. Soc. Med. 91:7-9.
6. Mousa HM, Woodley FW. 2012. Gastroesophageal reflux in cystic fibrosis: current understandings of mechanisms and management. Curr. Gastroenterol. Rep. 14:226-235. http://dx.doi.org/10.1007/s11894-012-0261-9.
7. Palm K, Sawicki G, Rosen R. 2012. The impact of reflux burden on Pseudomonas positivity in children with cystic fibrosis. Pediatr. Pulmonol. 47:582-587. http://dx.doi.org/10.1002/ppul.21598.
8. Pauwels A, Decraene A, Blondeau K, Mertens V, Farre R, Proesmans M, Van Bleyenbergh P, Sifrim D, Dupont LJ. 2012. Bile acids in sputum and increased airway inflammation in patients with cystic fibrosis. Chest 141: 1568-1574. http://dx.doi.org/10.1378/chest.11-1573.
9. Rascon-Aguilar IE, Pamer M, Wludyka P, Cury J, Coultas D, Lambiase LR, Nahman NS, Vega KJ. 2006. Role of gastroesophageal reflux symptoms in exacerbations of COPD. Chest 130:1096-1101. http://dx.doi.org/10.1378/chest.130.4.1096.
10. Wu YC, Hsu PK, Su KC, Liu LY, Tsai CC, Tsai SH, Hsu WH, Lee YC, Perng DW. 2009. Bile acid aspiration in suspected ventilator-associated pneumonia. Chest 136:118-124. http://dx.doi.org/10.1378/chest.08-2668.
11. D'Ovidio F, Mura M, Tsang M, Waddell TK, Hutcheon MA, Singer LG, Hadjiliadis D, Chaparro C, Gutierrez C, Pierre A, Darling G, Liu M, Keshavjee S. 2005. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation. J. Thorac. Cardiovasc. Surg. 129:1144-1152. http://dx.doi.org/10.1016/j.jtcvs.2004.10.035.
12. Reen FJ, Woods DF, Mooij MJ, Adams C, O'Gara F. 2012. Respiratory pathogens adopt a chronic lifestyle in response to bile. PLoS One 7:e45978. http://dx.doi.org/10.1371/journal.pone.0045978.
13. van der Doef HP, Arets HG, Froeling SP, Westers P, Houwen RH. 2009. Gastric acid inhibition for fat malabsorption or gastroesophageal reflux disease in cystic fibrosis: longitudinal effect on bacterial colonization and pulmonary function. J. Pediatr. 155:629-633. http://dx.doi.org/10.1016/j.jpeds.2009.06.040.
14. Vos R, Blondeau K, Vanaudenaerde BM, Mertens V, Van Raemdonck DE, Sifrim D, Dupont LJ, Verleden GM. 2008. Airway colonization and gastric aspiration after lung transplantation: do birds of a feather flock together? J. Heart Lung Transplant. 27:843-849. http://dx.doi.org/10.1016/j.healun.2008.05.022.
15. Gibson RL, Burns JL, Ramsey BW. 2003. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am. J. Respir. Crit. Care Med. 168:918-951. http://dx.doi.org/10.1164/rccm.200304-505SO.
16. O'Sullivan BP, Freedman SD. 2009. Cystic fibrosis. Lancet 373:1891-1904. http://dx.doi.org/10.1016/S0140-6736(09)60327-5.
17. Appel JZ, III, Lee SM, Hartwig MG, Li B, Hsieh CC, Cantu E, III, Yoon Y, Lin SS, Parker W, Davis RD. 2007. Characterization of the innate immune response to chronic aspiration in a novel rodent model. Respir. Res. 8:87. http://dx.doi.org/10.1186/1465-9921-8-87.
18. Eltzschig HK, Carmeliet P. 2011. Hypoxia and inflammation. N. Engl. J. Med. 364:656-665. http://dx.doi.org/10.1056/NEJMra0910283.
19. Nizet V, Johnson RS. 2009. Interdependence of hypoxic and innate immune responses. Nat. Rev. Immunol. 9:609-617. http://dx.doi.org/10.1038/nri2607.
20. Zinkernagel AS, Johnson RS, Nizet V. 2007. Hypoxia inducible factor (HIF) function in innate immunity and infection. J. Mol. Med. (Berl.) 85:1339-1346. http://dx.doi.org/10.1007/s00109-007-0282-2.
21. Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, Mackman N, Haase VH, Jaenisch R, Corr M, Nizet V, Firestein GS, Gerber HP, Ferrara N, Johnson RS. 2003. HIF-1alpha is essential for myeloid cellmediated inflammation. Cell 112:645-657. http://dx.doi.org/10.1016/S0092-8674(03)00154-5.
22. Wang GL, Jiang BH, Rue EA, Semenza GL. 1995. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. U. S. A. 92:5510-5514. http://dx.doi.org/10.1073/pnas.92.12.5510.
23. 2-regulated prolyl hydroxylation. Science 292:468-472. http://dx.doi.org/10.1126/science.1059796.
24. Schofield CJ, Ratcliffe PJ. 2005. Signalling hypoxia by HIF hydroxylases. Biochem. Biophys. Res. Commun. 338:617-626. http://dx.doi.org/10.1016/j.bbrc.2005.08.111.
25. Werth N, Beerlage C, Rosenberger C, Yazdi AS, Edelmann M, Amr A, Bernhardt W, von EiffC, Becker K, Schafer A, Peschel A, Kempf VAJ. 2010. Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens. PLoS One 5:e11576. http://dx.doi.org/10.1371/journal.pone.0011576.
26. Cane G, Ginouves A, Marchetti S, Busca R, Pouyssegur J, Berra E, Hofman P, Vouret-Craviari V. 2010. HIF-1alpha mediates the induction of IL-8 and VEGF expression on infection with Afa/Dr diffusely adhering E. coli and promotes EMT-like behaviour. Cell. Microbiol. 12:640-653. http://dx.doi.org/10.1111/j.1462-5822.2009.01422.x.
27. Rupp J, Gieffers J, Klinger M, van Zandbergen G, Wrase R, Maass M, Solbach W, Deiwick J, Hellwig-Burgel T. 2007. Chlamydia pneumoniae directly interferes with HIF-1alpha stabilization in human host cells. Cell. Microbiol. 9:2181-2191. http://dx.doi.org/10.1111/j.1462-5822.2007.00948.x.
28. Sharma M, Machuy N, Bohme L, Karunakaran K, Maurer AP, Meyer TF, Rudel T. 2011. HIF-1alpha is involved in mediating apoptosis resistance to Chlamydia trachomatis-infected cells. Cell. Microbiol. 13:1573-1585. http://dx.doi.org/10.1111/j.1462-5822.2011.01642.x.
29. Peyssonnaux C, Boutin AT, Zinkernagel AS, Datta V, Nizet V, Johnson RS. 2008. Critical role of HIF-1alpha in keratinocyte defense against bacterial infection. J. Investig. Dermatol. 128:1964-1968. http://dx.doi.org/10.1038/jid.2008.27.
30. Peyssonnaux C, Datta V, Cramer T, Doedens A, Theodorakis EA, Gallo RL, Hurtado-Ziola N, Nizet V, Johnson RS. 2005. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J. Clin. Invest. 115: 1806-1815. http://dx.doi.org/10.1172/JCI23865.
31. Legendre C, Mooij MJ, Adams C, O'Gara F. 2011. Impaired expression of hypoxia-inducible factor-1alpha in cystic fibrosis airway epithelial cells-a role for HIF-1 in the pathophysiology of CF? J. Cyst. Fibros. 10: 286-290. http://dx.doi.org/10.1016/j.jcf.2011.02.005.
32. Shao Z, Zhang Y, Ye Q, Saldanha JN, Powell-Coffman JA. 2010. C. elegans SWAN-1 binds to EGL-9 and regulates HIF-1-mediated resistance to the bacterial pathogen Pseudomonas aeruginosa PAO1. PLoS Pathog. 6:e1001075. http://dx.doi.org/10.1371/journal.ppat.1001075.
33. Legendre C, Reen FJ, Mooij MJ, McGlacken GP, Adams C, O'Gara F. 2012. Pseudomonas aeruginosa alkyl quinolones repress hypoxia-inducible factor 1 (HIF-1) signaling through HIF-1alpha degradation. Infect. Immun. 80:3985-3992. http://dx.doi.org/10.1128/IAI.00554-12.
34. Hitchcock PJ, Brown TM. 1983. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J. Bacteriol. 154:269-277.
35. Tack J. 2006. Review article: the role of bile and pepsin in the pathophysiology and treatment of gastro-oesophageal reflux disease. Aliment. Pharmacol. Ther. 24(Suppl 2):S10-S16. http://dx.doi.org/10.1111/j.1365-2036.2006.03040.x.
36. Hofmann AF. 1999. The continuing importance of bile acids in liver and intestinal disease. Arch. Intern. Med. 159:2647-2658. http://dx.doi.org/10.1001/archinte.159.22.2647.
37. Ferreira M, Coxito PM, Sardao VA, Palmeira CM, Oliveira PJ. 2005. Bile acids are toxic for isolated cardiac mitochondria: a possible cause for hepatic-derived cardiomyopathies? Cardiovasc. Toxicol. 5:63-73. http://dx.doi.org/10.1385/CT:5:1:063.
38. Begley M, Gahan CG, Hill C. 2002. Bile stress response in Listeria monocytogenes LO28: adaptation, cross-protection, and identification of genetic loci involved in bile resistance. Appl. Environ. Microbiol. 68:6005-6012. http://dx.doi.org/10.1128/AEM.68.12.6005-6012.2002.
39. Kim KS, Rajagopal V, Gonsalves C, Johnson C, Kalra VK. 2006. A novel role of hypoxia-inducible factor in cobalt chloride-and hypoxia-mediated expression of IL-8 chemokine in human endothelial cells. J. Immunol. 177:7211-7224. http://dx.doi.org/10.4049/jimmunol.177.10.7211.
40. Werno C, Menrad H, Weigert A, Dehne N, Goerdt S, Schledzewski K, Kzhyshkowska J, Brune B. 2010. Knockout of HIF-1alpha in tumorassociated macrophages enhances M2 polarization and attenuates their pro-angiogenic responses. Carcinogenesis 31:1863-1872. http://dx.doi.org/10.1093/carcin/bgq088.
41. Liou TG, Adler FR, Keogh RH, Li Y, Jensen JL, Walsh W, Packer K, Clark T, Carveth H, Chen J, Rogers SL, Lane C, Moore J, Sturrock A, Paine R, III, Cox DR, Hoidal JR. 2012. Sputum biomarkers and the prediction of clinical outcomes in patients with cystic fibrosis. PLoS One 7:e42748. http://dx.doi.org/10.1371/journal.pone.0042748.
42. McAllister F, Henry A, Kreindler JL, Dubin PJ, Ulrich L, Steele C, Finder JD, Pilewski JM, Carreno BM, Goldman SJ, Pirhonen J, Kolls JK. 2005. Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growthrelated oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. J. Immunol. 175:404-412. http://dx.doi.org/10.4049/jimmunol.175.1.404.
43. Osika E, Cavaillon JM, Chadelat K, Boule M, Fitting C, Tournier G, Clement A. 1999. Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease. Eur. Respir. J. 14:339-346.
44. Blau H, Klein K, Shalit I, Halperin D, Fabian I. 2007. Moxifloxacin but not ciprofloxacin or azithromycin selectively inhibits IL-8, IL-6, ERK1/2, JNK, and NF-kappaB activation in a cystic fibrosis epithelial cell line. Am. J. Physiol. Lung Cell. Mol. Physiol. 292:L343-L352. http://dx.doi.org/10.1152/ajplung.00030.2006.
45. Song S, Guha S, Liu K, Buttar NS, Bresalier RS. 2007. COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signalling pathways in Barrett's oesophagus and oesophageal adenocarcinoma. Gut 56:1512-1521. http://dx.doi.org/10.1136/gut.2007.121244.
46. Debruyne PR, Bruyneel EA, Karaguni IM, Li X, Flatau G, Muller O, Zimber A, Gespach C, Mareel MM. 2002. Bile acids stimulate invasion and haptotaxis in human colorectal cancer cells through activation of multiple oncogenic signaling pathways. Oncogene 21:6740-6750. http://dx.doi.org/10.1038/sj.onc.1205729.
47. Theisen J, Nehra D, Citron D, Johansson J, Hagen JA, Crookes PF, DeMeester SR, Bremner CG, DeMeester TR, Peters JH. 2000. Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids. J. Gastrointest. Surg. 4:50-54. http://dx.doi.org/10.1016/S1091-255X(00) 80032-3.
48. Drivas G, James O, Wardle N. 1976. Study of reticuloendothelial phagocytic capacity in patients with cholestasis. Br. Med. J. 1:1568-1569. http://dx.doi.org/10.1136/bmj.1.6025.1568.
49. Keane RM, Gadacz TR, Munster AM, Birmingham W, Winchurch RA. 1984. Impairment of human lymphocyte function by bile salts. Surgery 95:439-443.
50. Calmus Y, Guechot J, Podevin P, Bonnefis MT, Giboudeau J, Poupon R. 1992. Differential effects of chenodeoxycholic and ursodeoxycholic acids on interleukin 1, interleukin 6 and tumor necrosis factor-alpha production by monocytes. Hepatology 16:719-723. http://dx.doi.org/10.1002/hep.1840160317.
51. Greve JW, Gouma DJ, Buurman WA. 1989. Bile acids inhibit endotoxininduced release of tumor necrosis factor by monocytes: an in vitro study. Hepatology 10:454-458. http://dx.doi.org/10.1002/hep.1840100409.
52. Fielding CA, Jones GW, McLoughlin RM, McLeod L, Hammond VJ, Uceda J, Williams AS, Lambie M, Foster TL, Liao CT, Rice CM, Greenhill CJ, Colmont CS, Hams E, Coles B, Kift-Morgan A, Newton Z, Craig KJ, Williams JD, Williams GT, Davies SJ, Humphreys IR, O'Donnell VB, Taylor PR, Jenkins BJ, Topley N, Jones SA. 2014. Interleukin-6 signaling drives fibrosis in unresolved inflammation. Immunity 40:40-50. http://dx.doi.org/10.1016/j.immuni.2013.10.022.
53. Campbell EL, Bruyninckx WJ, Kelly CJ, Glover LE, McNamee EN, Bowers BE, Bayless AJ, Scully M, Saeedi BJ, Golden-Mason L, Ehrentraut SF, Curtis VF, Burgess A, Garvey JF, Sorensen A, NemenoffR, Jedlicka P, Taylor CT, Kominsky DJ, Colgan SP. 2014. Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation. Immunity 40:66-77. http://dx.doi.org/10.1016/j.immuni.2013.11.020.
54. Kawamata Y, Fujii R, Hosoya M, Harada M, Yoshida H, Miwa M, Fukusumi S, Habata Y, Itoh T, Shintani Y, Hinuma S, Fujisawa Y, Fujino M. 2003. A G protein-coupled receptor responsive to bile acids. J. Biol. Chem. 278:9435-9440. http://dx.doi.org/10.1074/jbc. M209706200.
55. Gomez MI, Sokol SH, Muir AB, Soong G, Bastien J, Prince AS. 2005. Bacterial induction of TNF-alpha converting enzyme expression and IL-6 receptor alpha shedding regulates airway inflammatory signaling. J. Immunol. 175:1930-1936. http://dx.doi.org/10.4049/jimmunol.175.3.1930.
56. Tang A, Sharma A, Jen R, Hirschfeld AF, Chilvers MA, Lavoie PM, Turvey SE. 2012. Inflammasome-mediated IL-1beta production in humans with cystic fibrosis. PLoS One 7:e37689. http://dx.doi.org/10.1371/journal.pone.0037689.